CRP and Crohn disease: One case series in 16 adults with active Crohn's disease treated with exclusive enteral nutrition as an adjuvant to existing Crohn's disease medications (details not provided)102 showed significant reductions in Harvey Bradshaw index (6.5 ± 5.8 to 2.4 ± 3.3) (p = 0.001) and CRP (3.5–0.88 mg dl–1) (p = 0.023).